Search

everythinglearnresearchcommunity

for

Search:↓

Canagliflozin helps overcome progestin resistance in certain endometrial cancer cells.

Testosterone patches can modestly improve sexual function in postmenopausal women not on estrogen therapy.

Dihydrotestosterone makes arteries stiffer in female mice by reducing estrogen receptor expression.

Non-hormonal treatments should be used first for sexual dysfunction in postmenopausal breast cancer patients on aromatase inhibitors, with hormones as a second option.

Hormones during puberty increase certain receptors in the brain, and this change is influenced by estrogen levels.

Progesterone reduces anxiety and depression in female mice by increasing BDNF in the brain, needing 5α-reduction and estradiol.

Male hormones may play a role in the development of heart disease, and more research is needed to understand their effects.

Future osteoporosis treatments should focus on increasing bone growth, with many promising options available.

Skin aging is caused by stem cell damage and can potentially be delayed with treatments like antioxidants and stem cell therapy.

Progesterone byproduct 5αP stimulates mammary tumor growth, but finasteride can suppress it.

Finasteride treatment changes brain steroid levels and receptors, affecting brain function even after stopping treatment.

Finasteride slows down motherly behavior in first-time pregnant rats.

Targeting vitamin D and androgen receptors may effectively treat triple-negative breast cancer, especially with chemotherapy.

Finasteride effectively treats hair loss and enlarged prostate in men, with mild side effects.

Finasteride helps reduce heart enlargement in heart failure patients.

Frontal Fibrosing Alopecia is a type of hair loss affecting mostly older women, with no agreed best treatment.

Hormonal changes and psychological issues can cause sexual dysfunction in postmenopausal women. Behavioral therapy is recommended first, with hormone replacement helping some symptoms but not libido. Testosterone can improve libido, but its effects on overall sexual function are unclear. Emotional and relationship issues should be addressed before using medication, and the benefits and risks of testosterone supplementation should be considered.

Androgen replacement therapy can improve libido and mood in women with severe androgen deficiency, but more research is needed on its long-term safety.

Finasteride and minoxidil are effective for hair regrowth, while treatments for alopecia areata have varying success and continuous treatment is necessary.

RANK is a key target in breast cancer treatment due to its role in tumor growth and bone metastasis.

Taking DHEA for a year is generally safe for postmenopausal women but may cause acne and more facial hair without improving metabolism or aging.

The research identified and described a gene important for hormone conversion in endangered catfish, which varies in activity during different reproductive stages and after hormone treatment.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

5α-reductase inhibitors can cause serious and possibly lasting sexual and psychological side effects.

Endocrine therapies for cancer significantly increase the risk of hair loss.

Gonadal hormones significantly affect the severity of alopecia areata in mice.

Finasteride helps reduce heart issues and improves heart function.

Using finasteride or dutasteride does not increase the risk of male breast cancer.

Certain HSD3B1 gene types are linked to worse prostate cancer outcomes and affect treatment response and other health conditions.

DHEA may help with sexual function when used intravaginally by menopausal women but is similar to hormone therapy in other aspects and might cause more side effects like acne and hair loss.